Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis
- PMID: 38787555
- PMCID: PMC11127127
- DOI: 10.1001/jamanetworkopen.2024.13157
Red Flag Signs and Symptoms for Patients With Early-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis
Abstract
Importance: Early-onset colorectal cancer (EOCRC), defined as a diagnosis at younger than age 50 years, is increasing, and so-called red flag signs and symptoms among these individuals are often missed, leading to diagnostic delays. Improved recognition of presenting signs and symptoms associated with EOCRC could facilitate more timely diagnosis and impact clinical outcomes.
Objective: To report the frequency of presenting red flag signs and symptoms among individuals with EOCRC, to examine their association with EOCRC risk, and to measure variation in time to diagnosis from sign or symptom presentation.
Data sources: PubMed/MEDLINE, Embase, CINAHL, and Web of Science were searched from database inception through May 2023.
Study selection: Studies that reported on sign and symptom presentation or time from sign and symptom presentation to diagnosis for patients younger than age 50 years diagnosed with nonhereditary CRC were included.
Data extraction and synthesis: Data extraction and quality assessment were performed independently in duplicate for all included studies using Preferred Reporting Items for Systematic Reviews and Meta-analyses reporting guidelines. Joanna Briggs Institute Critical Appraisal tools were used to measure risk of bias. Data on frequency of signs and symptoms were pooled using a random-effects model.
Main outcomes and measures: Outcomes of interest were pooled proportions of signs and symptoms in patients with EOCRC, estimates for association of signs and symptoms with EOCRC risk, and time from sign or symptom presentation to EOCRC diagnosis.
Results: Of the 12 859 unique articles initially retrieved, 81 studies with 24 908 126 patients younger than 50 years were included. The most common presenting signs and symptoms, reported by 78 included studies, were hematochezia (pooled prevalence, 45% [95% CI, 40%-50%]), abdominal pain (pooled prevalence, 40% [95% CI, 35%-45%]), and altered bowel habits (pooled prevalence, 27% [95% CI, 22%-33%]). Hematochezia (estimate range, 5.2-54.0), abdominal pain (estimate range, 1.3-6.0), and anemia (estimate range, 2.1-10.8) were associated with higher EOCRC likelihood. Time from signs and symptoms presentation to EOCRC diagnosis was a mean (range) of 6.4 (1.8-13.7) months (23 studies) and a median (range) of 4 (2.0-8.7) months (16 studies).
Conclusions and relevance: In this systematic review and meta-analysis of patients with EOCRC, nearly half of individuals presented with hematochezia and abdominal pain and one-quarter with altered bowel habits. Hematochezia was associated with at least 5-fold increased EOCRC risk. Delays in diagnosis of 4 to 6 months were common. These findings highlight the need to identify concerning EOCRC signs and symptoms and complete timely diagnostic workup, particularly for individuals without an alternative diagnosis or sign or symptom resolution.
Conflict of interest statement
Figures




Similar articles
-
Trends and Symptoms Among Increasing Proportion of African Americans with Early-Onset Colorectal Cancer over a 60-Year Period.Dig Dis Sci. 2025 Jan;70(1):168-176. doi: 10.1007/s10620-024-08739-5. Epub 2024 Nov 25. Dig Dis Sci. 2025. PMID: 39586927 Free PMC article.
-
Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer.J Natl Cancer Inst. 2023 Aug 8;115(8):909-916. doi: 10.1093/jnci/djad068. J Natl Cancer Inst. 2023. PMID: 37138415 Free PMC article.
-
Epidemiology of Colorectal Cancer in Average Risk Adults 20-39 Years of Age: A Population-Based National Study.Dig Dis Sci. 2019 Dec;64(12):3602-3609. doi: 10.1007/s10620-019-05690-8. Epub 2019 Jun 7. Dig Dis Sci. 2019. PMID: 31175493 Free PMC article.
-
Association of diabetes mellitus with early-onset colorectal cancer: A systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events.Diabetes Metab Syndr. 2023 Aug;17(8):102828. doi: 10.1016/j.dsx.2023.102828. Epub 2023 Jul 14. Diabetes Metab Syndr. 2023. PMID: 37490785
-
Association of Body Mass Index With Risk of Early-Onset Colorectal Cancer: Systematic Review and Meta-Analysis.Am J Gastroenterol. 2021 Nov 1;116(11):2173-2183. doi: 10.14309/ajg.0000000000001393. Am J Gastroenterol. 2021. PMID: 34309586 Free PMC article.
Cited by
-
Stage-specific characterization of "early-onset colorectal cancer": Localized and synchronous metastatic disease.Int J Cancer. 2025 Jun 15;156(12):2340-2351. doi: 10.1002/ijc.35336. Epub 2025 Jan 30. Int J Cancer. 2025. PMID: 39887374 Free PMC article.
-
Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection.Sensors (Basel). 2024 Jul 20;24(14):4712. doi: 10.3390/s24144712. Sensors (Basel). 2024. PMID: 39066110 Free PMC article. Review.
-
Prognostic Differences Between Early-Onset and Late-Onset Colorectal Cancer.Medicina (Kaunas). 2025 Feb 24;61(3):390. doi: 10.3390/medicina61030390. Medicina (Kaunas). 2025. PMID: 40142201 Free PMC article.
-
Fear of cancer recurrence in long-term colorectal cancer survivors: a nationwide cross-sectional study.J Cancer Surviv. 2025 Jan 27. doi: 10.1007/s11764-025-01746-z. Online ahead of print. J Cancer Surviv. 2025. PMID: 39871027
-
Colorectal cancer in pregnancy: case discussions and real-world data as well as literature review on current knowledge.Oncologist. 2025 Jul 4;30(7):oyaf097. doi: 10.1093/oncolo/oyaf097. Oncologist. 2025. PMID: 40437693 Free PMC article. Review.